Background— Common single nucleotide polymorphisms (SNPs) at chromosomes 4q25 (rs2200733,
rs10033464 near PITX2), 1q21 (rs13376333 in KCNN3), and 16q22 (rs7193343 …

Cardiac sarcoidosis can mimic any cardiomyopathy in different stages. Noncaseating
granulomatous inflammation can be missed, because of the nonhomogeneous distribution in the …

Aims Catheter ablation is an established therapy in patients with symptomatic atrial fibrillation
(AF) with increasing popularity. Pericardial effusion requiring intervention (PE) is one of …

Aims Atrial fibrillation (AFib) and atrial flutter (AFlut) are common arrhythmias with increased
use of invasive procedures. A steady re-evaluation of relevant safety endpoints is …

Background— The angiotensin-converting enzyme (ACE) deletion allele, ACE D, is
associated with increased cardiac ACE activity, cardiac fibrosis, and adverse outcomes in …

Background Hypertrophic cardiomyopathy (HCM) is the most common inherited heart
disease. Reported prevalence rates vary substantially between 1:500 (0.2%) and 1:3,000 (0.03%), …

Background Galectin-3 (Gal-3) is an emerging biomarker in heart failure that is involved in
fibrosis and inflammation. However, its potential value as a prognostic marker in atrial …

Background: Ablation is a widely used therapy for atrial fibrillation (AF); however, arrhythmia
recurrence and repeat procedures are common. Studies examining surrogate markers of …

Objective Atrial fibrillation or atrial flutter (AF) and heart failure (HF) often go hand in hand
and, in combination, lead to an increased risk of death compared with patients with just one of …

Aims Several reports indicate lower rates of emergency admissions in the cardiovascular
sector and reduced admissions of patients with chronic diseases during the Coronavirus SARS-…